Aandeel 8622 HUAKANG BIOMEDICAL HOLDINGS COMPANY LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Huakang Biomedical Holdings Company Limited

Aandelen

8622

KYG4644W1069

Beurs gesloten - Hong Kong S.E.
Andere beurzen
 10:09:00 03-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,098 HKD 0,00% Intraday-grafiek van Huakang Biomedical Holdings Company Limited -3,92% -8,41%
28/03 Huakang Biomedical Holdings Company Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI
25/03 Huakang Biomedical Holdings Company Limited geeft richtlijnen voor de groepswinst voor het jaar eindigend op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Huakang Biomedical Holdings Company Limited Provides Group Earnings Guidance for the Year Ended 31 December 2023
An unknown buyer acquired 15.59% stake in Huakang Biomedical Holdings Company Limited from Ever Charming Inc for HKD 3.2 million.
Huakang Biomedical Holdings Company Limited Announces Change of Address of Head Office, Effect from 18 December 2023
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Huakang Biomedical Holdings Company Limited Appoints Chow Ching Man as Independent Non-Executive Director Member of Audit Committee and Nomination Committee
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Huakang Biomedical Holdings Company Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2021
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Huakang Biomedical Holdings Company Limited Provides Group Earnings Guidance for the Nine Months Ended September 30, 2021
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
Huakang Biomedical Holdings Company Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2021
Huakang Biomedical Holdings Company Limited Provides Unaudited Consolidated Earnings Guidance for the Three Months Ended March 31, 2021
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2020
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 8622
  4. Nieuws Huakang Biomedical Holdings Company Limited
  5. Andere talen